Association of antecedent cardiovascular risk factor levels and trajectories with cardiovascular magnetic resonance-derived cardiac function and structure.


Journal

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
ISSN: 1532-429X
Titre abrégé: J Cardiovasc Magn Reson
Pays: England
ID NLM: 9815616

Informations de publication

Date de publication:
04 01 2021
Historique:
received: 29 07 2020
accepted: 09 12 2020
entrez: 4 1 2021
pubmed: 5 1 2021
medline: 17 8 2021
Statut: epublish

Résumé

The association of longitudinal trajectories of cardiovascular risk factors with cardiovascular magnetic resonance (CMR)-measures of cardiac structure and function in the community is not well known. Therefore we aimed to relate risk factor levels from different examination cycles to CMR-measures of the left ventricle (LV) and right ventricle in a population-based cohort. We assessed conventional cardiovascular disease risk factors in 349 participants (143 women; aged 25-59 years) at three examination cycles (Exam 1 [baseline], at Exam 2 [7-years follow-up] and at Exam 3 [14-years follow-up]) of the KORA S4 cohort and related single-point measurements of individual risk factors and longitudinal trajectories of these risk factors to various CMR-measures obtained at Exam 3. High levels of diastolic blood pressure, waist circumference, and LDL-cholesterol at the individual exams were associated with worse cardiac function and structure. Trajectory clusters representing higher levels of the individual risk factors were associated with worse cardiac function and structure compared to low risk trajectory clusters of individual risk factors. Multivariable (combining different risk factors) trajectory clusters were associated with different cardiac parameters in a graded fashion (e.g. decrease of LV stroke volume for middle risk cluster β = - 4.91 ml/m Cardiovascular disease risk factor levels, measured over a time period of 14 years, were associated with CMR-derived measures of cardiac structure and function. Longitudinal multivariable trajectory clusters explained a greater proportion of the inter-individual variation in cardiac traits than multiple risk factor assessed contemporaneous with the CMR exam.

Sections du résumé

BACKGROUND
The association of longitudinal trajectories of cardiovascular risk factors with cardiovascular magnetic resonance (CMR)-measures of cardiac structure and function in the community is not well known. Therefore we aimed to relate risk factor levels from different examination cycles to CMR-measures of the left ventricle (LV) and right ventricle in a population-based cohort.
METHODS
We assessed conventional cardiovascular disease risk factors in 349 participants (143 women; aged 25-59 years) at three examination cycles (Exam 1 [baseline], at Exam 2 [7-years follow-up] and at Exam 3 [14-years follow-up]) of the KORA S4 cohort and related single-point measurements of individual risk factors and longitudinal trajectories of these risk factors to various CMR-measures obtained at Exam 3.
RESULTS
High levels of diastolic blood pressure, waist circumference, and LDL-cholesterol at the individual exams were associated with worse cardiac function and structure. Trajectory clusters representing higher levels of the individual risk factors were associated with worse cardiac function and structure compared to low risk trajectory clusters of individual risk factors. Multivariable (combining different risk factors) trajectory clusters were associated with different cardiac parameters in a graded fashion (e.g. decrease of LV stroke volume for middle risk cluster β = - 4.91 ml/m
CONCLUSIONS
Cardiovascular disease risk factor levels, measured over a time period of 14 years, were associated with CMR-derived measures of cardiac structure and function. Longitudinal multivariable trajectory clusters explained a greater proportion of the inter-individual variation in cardiac traits than multiple risk factor assessed contemporaneous with the CMR exam.

Identifiants

pubmed: 33390171
doi: 10.1186/s12968-020-00698-w
pii: 10.1186/s12968-020-00698-w
pmc: PMC7780638
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2

Références

Radiology. 2015 Oct;277(1):206-20
pubmed: 25989618
Circulation. 2010 Aug 10;122(6):570-8
pubmed: 20660804
Hypertension. 1995 Mar;25(3):305-13
pubmed: 7875754
J Hypertens. 2012 Sep;30(9):1862-73
pubmed: 22796707
Cardiovasc Diabetol. 2018 Jun 12;17(1):88
pubmed: 29895299
PLoS One. 2016 Oct 17;11(10):e0164704
pubmed: 27749939
Obesity (Silver Spring). 2009 Mar;17(3):559-63
pubmed: 19131940
Circulation. 2002 Jan 1;105(1):48-53
pubmed: 11772875
Am J Cardiol. 2010 Jul 1;106(1):110-6
pubmed: 20609657
Sci Rep. 2019 Dec 9;9(1):18616
pubmed: 31819090
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):625-30
pubmed: 23539476
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
Am J Hypertens. 2017 Jun 1;30(6):587-593
pubmed: 28338937
PLoS One. 2017 Oct 3;12(10):e0185114
pubmed: 28973022
Eur Cardiol. 2014 Jul;9(1):37-42
pubmed: 30310483
Int J Epidemiol. 2015 Apr;44(2):578-86
pubmed: 26016847
Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3
pubmed: 2520314
Sci Rep. 2019 Nov 18;9(1):16972
pubmed: 31740739
J Hypertens. 2003 Nov;21(11):1983-92
pubmed: 14597836
J Am Coll Cardiol. 2006 Dec 5;48(11):2285-92
pubmed: 17161261
BMC Cardiovasc Disord. 2017 Jul 27;17(1):206
pubmed: 28750662
Eur J Heart Fail. 2011 Jan;13(1):18-28
pubmed: 20685685
J Am Soc Hypertens. 2015 Sep;9(9):690-696.e1
pubmed: 26260423
Nat Rev Cardiol. 2011 Oct 25;8(12):673-85
pubmed: 22027657
Am J Cardiol. 2010 May 1;105(9):1297-9
pubmed: 20403482
PLoS One. 2016 May 20;11(5):e0155978
pubmed: 27203599
Obesity (Silver Spring). 2013 Nov;21(11):2180-8
pubmed: 24136924
BMC Cardiovasc Disord. 2018 Aug 9;18(1):162
pubmed: 30092757
Hypertension. 2007 Nov;50(5):869-76
pubmed: 17893376
Nutr Metab Cardiovasc Dis. 2016 Sep;26(9):815-23
pubmed: 27397510
Diabetologia. 2005 Jan;48(1):27-34
pubmed: 15616798
Eur Radiol. 2018 Jul;28(7):3105-3113
pubmed: 29423576
J Hypertens. 2006 Feb;24(2):293-9
pubmed: 16508575
Br J Radiol. 2019 Apr;92(1096):20180562
pubmed: 30633543
Diabetes. 2017 Jan;66(1):158-169
pubmed: 27999110
Diabetes Res Clin Pract. 2014 Sep;105(3):416-23
pubmed: 24972524
Epidemiology. 1997 Mar;8(2):150-6
pubmed: 9229206
JAMA Cardiol. 2018 Nov 1;3(11):1096-1100
pubmed: 30193291
Circulation. 2009 Dec 8;120(23):2345-51
pubmed: 19933936

Auteurs

Roberto Lorbeer (R)

Department of Radiology, University Hospital, LMU Munich, Pettenkoferstr. 8a, 80336, Munich, Germany. roberto.lorbeer@med.uni-muenchen.de.
German Center for Cardiovascular Disease Research (DZHK E.V.), Munich, Germany. roberto.lorbeer@med.uni-muenchen.de.

Susanne Rospleszcz (S)

German Center for Cardiovascular Disease Research (DZHK E.V.), Munich, Germany.
Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.
Chair of Epidemiology, Institute of Medical Information Processing, Biometrics and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany.

Christopher L Schlett (CL)

Department of Diagnostic and Interventional Radiology, Medical Center, University Freiburg, Freiburg, Germany.

Sophia D Rado (SD)

Department of Diagnostic and Interventional Radiology, Eberhard Karl University Tübingen, Tübingen, Germany.

Barbara Thorand (B)

Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.
German Center for Diabetes Research (DZD E.V.), Neuherberg, Germany.

Christa Meisinger (C)

Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.
Chair of Epidemiology, LMU Munich, UNIKA-T Augsburg, Augsburg, Germany.

Wolfgang Rathmann (W)

Institute for Biometrics and Epidemiology, German Diabetes Center, Düsseldorf, Germany.
Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.

Margit Heier (M)

Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.
KORA Study Centre, University Hospital of Augsburg, Augsburg, Germany.

Ramachandran S Vasan (RS)

Preventive Medicine and Epidemiology Section, Boston University School of Medicine and Framingham Heart Study, Framingham, MA, USA.

Fabian Bamberg (F)

Department of Diagnostic and Interventional Radiology, Medical Center, University Freiburg, Freiburg, Germany.

Annette Peters (A)

German Center for Cardiovascular Disease Research (DZHK E.V.), Munich, Germany.
Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.
Chair of Epidemiology, Institute of Medical Information Processing, Biometrics and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany.
German Center for Diabetes Research (DZD E.V.), Neuherberg, Germany.

Wolfgang Lieb (W)

Institute of Epidemiology, Kiel University, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH